{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:03Z","timestamp":1787070783860,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives of the Study:<\/jats:title>\n                    <jats:p>To evaluate platelet indices and basic blood coagulation parameters in various stages of CKD patients and to find out any correlation between patients\u2019 coagulation parameters and CKD staging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>It was a 2-year prospective observational study conducted in the Department of Hematology in a tertiary care hospital. Sample size was 160, out of which 80 were cases and 80 were age and gender matched controls. Patients of both sexes and age group ranging \u226520 years belonging to various stages of non-dialyzed CKD were included in the study. Platelet parameters studied were platelet count and platelet indices like Mean platelet volume (MPV) or platelet distribution width (PDW) and coagulation parameters studied were Prothrombin time (PT), International normalized ratio (INR), activated partial thromboplastin time (aPTT), Fibrin degradation products (FDP), D-dimer and fibrinogen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis:<\/jats:title>\n                    <jats:p>The data obtained was be analyzed by using SPSS version 25 software. The results were expressed as the mean \u00b1 SD for continuous data and as percentage or frequency for categorical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The most common agegroup of CKD patients was found out to be 51-60 years (34.5%). Most common clinical feature with which patients presented to the clinic was weakness and lethargy (41.2%). Majority of the patients belonged to CKD stage III (51.2%) followed by CKD. The most common cause of CKD was diabetic nephropathy (33.1%), followed by hypertensive nephropathy (25.6%). Mean Platelet count was lowest in CKD stage 5 (0.96 \u00b1 0.11 \u00d7 10\n                      <jats:sup>3<\/jats:sup>\n                      \/\u03bcl). PDW showed a positive correlation with mean platelet count, suggesting a hyperproliferative kind of thrombocytopenia in CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Monitoring of primary and secondary hemostatic parameters is of utmost importance in predicting bleeding and thrombotic risks in CKD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_830_25","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:01:18Z","timestamp":1774008078000},"page":"943-948","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hemostatic imbalances in chronic kidney disease: A regional perspective from Bihar"],"prefix":"10.4103","volume":"15","author":[{"given":"Iffat","family":"Jamal","sequence":"first","affiliation":[{"name":"Department of Pathology (Hematology Section), Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shuchismita","sequence":"additional","affiliation":[{"name":"Department of Pathology (Hematology Section), Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi B.","family":"Raman","sequence":"additional","affiliation":[{"name":"Department of Pathology (Hematology Section), Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prit P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayanand","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of Pathology (Hematology Section), Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"R1-20260325","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jcp.21.3.406","article-title":"Hemostatic Mechanism in uraemia","volume":"21","author":"Hutton","year":"1968","journal-title":"J Clin Pathol"},{"key":"R2-20260325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R3-20260325","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1161\/STROKEAHA.107.489807","article-title":"Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: The Rotterdam study","volume":"38","author":"Bos","year":"2007","journal-title":"Stroke"},{"key":"R4-20260325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.semnephrol.2005.06.011","article-title":"Coagulation disorders in uremia","volume":"26","author":"Molino","year":"2006","journal-title":"Semin Nephrol"},{"key":"R5-20260325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1160\/TH10-12-0785","article-title":"Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease","volume":"106","author":"Darlington","year":"2011","journal-title":"Thromb Haemost"},{"key":"R6-20260325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: An update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"R7-20260325","doi-asserted-by":"crossref","first-page":"100604","DOI":"10.1016\/j.xkme.2023.100604","article-title":"CKD progression risk and subsequent cause of death: A population based cohort study","volume":"5","author":"Rai","year":"2023","journal-title":"Kidney Med"},{"key":"R8-20260325","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2215\/CJN.09180817","article-title":"Chronci kidney disease in India","volume":"13","author":"Varughese","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20260325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21276\/apalm.3015","article-title":"Impact of haemodialysis on coagulation profile in chronic kidney disease","volume":"8","author":"Raja","year":"2021","journal-title":"Ann Pathol Lab Med"},{"key":"R10-20260325","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.18410\/jebmh\/2018\/399","article-title":"Hematological changes in pre and post hemodialysis in patients with chronic renal failure","volume":"5","author":"Gautam","year":"2018","journal-title":"J Evid Based Med Health"},{"key":"R11-20260325","first-page":"22","article-title":"The effect of hemodialysis on hemoglobin concentration, platelets count and white blood cells count in end stage renal failure","volume":"5","author":"Hakim","year":"2016","journal-title":"Int J Med Res Heal Sci"},{"key":"R12-20260325","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/s-0038-1653865","article-title":"Marked increase of activated factor VII in uremic patients","volume":"73","author":"Kario","year":"1995","journal-title":"Thromb Haemost"},{"key":"R13-20260325","first-page":"135","article-title":"Hemostatic abnormalities in severe renal failure: Do they bark or bite","volume":"28","author":"Mohapatra","year":"2018","journal-title":"Indian J Nephrol"},{"key":"R14-20260325","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0272-6386(12)80136-3","article-title":"Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: Effect of hemodialysis","volume":"23","author":"Vaziri","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R15-20260325","first-page":"CR55","article-title":"Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis","volume":"12","author":"Kirmizis","year":"2006","journal-title":"Med Sci Monit"},{"key":"R16-20260325","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","article-title":"Inflammation, hemostasis, and the risk of kidney function decline in the atherosclerosis risk in communities (ARIC) study","volume":"53","author":"Bash","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R17-20260325","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1646627","article-title":"Plasma D dimer: A useful marker of fibrin breakdown in renal failure","volume":"61","author":"Gordge","year":"1989","journal-title":"Thromb Haemost"},{"key":"R18-20260325","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.1984.tb03953.x","article-title":"The significance of fibrinogen derivatives in plasma in human renal failure","volume":"56","author":"Lane","year":"1984","journal-title":"Br J Haematol"},{"key":"R19-20260325","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0008-6363(02)00857-X","article-title":"Infection and inflammation and the coagulation system","volume":"60","author":"Levi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R20-20260325","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/ndt\/16.4.798","article-title":"Changes in major blood components after adopting the supine position during haemodialysis","volume":"16","author":"Inagaki","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R21-20260325","doi-asserted-by":"crossref","first-page":"e014294","DOI":"10.1136\/bmjopen-2016-014294","article-title":"Blood coagulation system in patients with chronic kidney disease: A prospective observational study","volume":"7","author":"Huang","year":"2017","journal-title":"BMJ Open"},{"key":"R22-20260325","first-page":"149","article-title":"Coagulation study in uraemia","volume":"28","author":"Shetty","year":"1982","journal-title":"J Postgrad Med"},{"key":"R23-20260325","first-page":"1","article-title":"Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis","volume":"21","author":"Martinez","year":"1999","journal-title":"Clin Hemorheol Microcire"},{"key":"R24-20260325","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.2830070203","article-title":"Bleeding time in uremia: A useful test to assess clinical bleeding","volume":"7","author":"Steiner","year":"1979","journal-title":"Am J Hematol"},{"key":"R25-20260325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1650576","article-title":"Haemostatic disorder of uremia: The platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis","volume":"76","author":"Mezzano","year":"1996","journal-title":"Thromb Haemost"},{"key":"R26-20260325","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1681\/ASN.V1271549","article-title":"The microinflammatory state in Uremia: Causes and potential consequences","volume":"12","author":"Kaysen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R27-20260325","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.3390\/ijms25168705","article-title":"Hallmarks for thrombotic and hemorrhagic risks in chronic kidney disease patients","volume":"25","author":"Saeed","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_830_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:36:33Z","timestamp":1787067393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_830_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_830_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"2025-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}